Abbott India Limited (NSE:ABBOTINDIA)
India · Delayed Price · Currency is INR 27,780
+55 (0.20%)
At close: Jan 23, 2026
Abbott India Market Cap
Abbott India has a market cap or net worth of 591.36 billion as of January 23, 2026. Its market cap has decreased by -7.05% in one year.
Market Cap
591.36B
Enterprise Value
569.77B
Revenue
67.14B
Ranking
n/a
PE Ratio
39.19
Stock Price
27,780.00
Market Cap Chart
Since February 21, 2002, Abbott India's market cap has increased from 4.77B to 591.36B, an increase of 12,299.46%. That is a compound annual growth rate of 22.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 591.36B | -4.27% |
| Dec 31, 2025 | 617.71B | -2.27% |
| Dec 31, 2024 | 632.08B | 30.17% |
| Dec 29, 2023 | 485.60B | 6.63% |
| Dec 30, 2022 | 455.40B | 10.06% |
| Dec 31, 2021 | 413.77B | 23.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cipla | 1.06T |
| Zydus Lifesciences | 887.50B |
| Mankind Pharma | 870.03B |
| Alkem Laboratories | 687.56B |
| Aurobindo Pharma | 657.76B |
| Glenmark Pharmaceuticals | 555.29B |
| Laurus Labs | 548.71B |
| Ipca Laboratories | 371.12B |